The global insufflation devices market size is expected to be worth around US$ 5.76 billion by 2030, according to a new report by Vision Research Reports.
The global insufflation devices market size was valued at US$ 5.31 billion in 2020 and is anticipated to grow at a CAGR of 9.3% during forecast period 2021 to 2030.
Get Sample Copy of This Report (Including TOC, List of Tables & Figures, and Chart)@ https://www.visionresearchreports.com/report/sample/38604
Insufflation Devices Market (By Application: Laparoscopic Surgery, Bariatric Surgery, Cardiac Surgery, Other Surgeries; By End-use: Hospitals, Clinics, Ambulatory Surgical Centers) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030
|Market Size||USD 5.76 billion by 2030|
|Growth Rate||CAGR of 9.3% From 2021 to 2030|
|Historic Data||2017 to 2020|
|Forecast Period||2021 to 2030|
|Segments Covered||Application, End use|
|Regional Scope||North America, Europe, Asia Pacific, Latin America, Middle East & Africa|
|Companies Mentioned||Fujifilm; Medtronic; Stryker; BD; Olympus; B. Braun Melsungen; Smith & Nephew; Karl Storz; Steris; CONMED; Richard Wolf|
Increasing adoption of minimally invasive surgeries, rapidly aging population, and rising number of laparoscopic procedures are among the major factors driving this market’s growth.
The COVID-19 outbreakhas caused the global implementation of strict measures to curbthe spread, which has led to the cancelation/delayof elective surgeries, including many laparoscopic procedures world wide. A large number of medical device manufacturing companies and global suppliers have been adversely affected during this time. However, with the abundance of deferred medical procedures in the pipeline, the market is likely to rebound and grow significantly over the forecast period.
The laparoscopic surgery segment held the largest share of over 35.0% in 2020 and is anticipated to witness considerable growth over the forecast period. The increasing cases of different laparoscopic surgical techniques, such as laparoscopic cholecystectomy, laparoscopic hernia repair, laparoscopic splenectomy, and laparoscopic hepatectomy, across the globe, are driving the segment.
The other surgeries segment is expected to expand at the highest CAGR of 7.1% from the forecast period. The increasing number of surgeries such as carotid artery surgery, cataract surgery, and tonsillectomy is expected to drive the segment.
The hospitals segment held the largest share of more than 60.0% in 2020. The growth of this segment can be attributed to the upsurge in surgical procedures globally because of a sedentary lifestyle, bad dietary habits, and rising cancer cases, which require the use of insufflation devices.
The ambulatory surgical centers segment is anticipated to register the fastest growth rate of 7.4% over the forecast period. An increase in the demand for minimally invasive surgeries, such as laparoscopic surgery, and increasing adoption of technologically advanced medical products by ambulatory surgical centers are a few factors fueling the market growth.
North America dominated the market with as hare of over 35.0% in 2020 and is expected to witness considerable growth over the forecast period. The growth of this regional market is attributed to the increase in the prevalence of laparoscopic surgeries, such as hysterectomy and cholecystectomy, and a rise in the demand for minimally invasive procedures.
- B. Braun Melsungen
- Smith & Nephew
- Karl Storz
- Richard Wolf
- Laparoscopic Surgery
- Bariatric Surgery
- Cardiac Surgery
- Other Surgeries
- Ambulatory Surgical Centers
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- North America
Buy This Premium Research Report, click here@ https://www.visionresearchreports.com/report/cart/38604 or call: +1 9197 992 333